Product Information
CEFIXIME 200 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $4.0251 per ML under NDC 68180040703. Its NADAC has been published 372 times since Oct 21, 2015.
Strength
200 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040703
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA065355On Market Since
4/24/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 200 MG/5 ML SUSP has been published 372 times since Oct 21, 2015, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0251 per ML |
|---|---|
| All-time high | $6.6362 (Feb 10, 2016) |
| All-time low | $2.8025 (Apr 17, 2024) |
| 52-week high | $5.6100 |
| 52-week low | $3.5799 |
| Median price | $5.6301 |
| Average price | $5.5162 |
| Largest weekly change | -42.4% (Apr 17, 2024) |
| Weeks tracked | 372 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFIXIME 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 200 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $4.0251 per ML (NDC 68180040703), effective Jun 24, 2026.
How has the price of CEFIXIME 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 200 MG/5 ML SUSP has declined 37.0%. It has been tracked across 372 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for CEFIXIME 200 MG/5 ML SUSP?
Since Oct 21, 2015, the NADAC for CEFIXIME 200 MG/5 ML SUSP has ranged from a low of $2.8025 (Apr 17, 2024) to a high of $6.6362 (Feb 10, 2016), with a median of $5.6301 per ML.
Are there cheaper alternatives to CEFIXIME 200 MG/5 ML SUSP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CEFIXIME 200 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures CEFIXIME 200 MG/5 ML SUSP?
CEFIXIME 200 MG/5 ML SUSP (NDC 68180040703) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification